Application of software design principles and debugging methods to an analgesia prescription reduces risk of severe injury from medical use of opioids

Clinical Pharmacology and Therapeutics

Volumn 84, Issue 3, 2008, Pages 385-392

  Belknap, S M ^a,b,c   Moore, H ^b   Lanzotti, S A ^c   Yarnold, P R ^a   Getz, M ^c   Deitrick, D L ^c   Peterson, A ^c   Akeson, J ^c   Maurer, T ^c   Soltysik, R C ^d   Storm, G A ^c   Brooks, I ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c OSF SAINT FRANCIS MEDICAL CENTER   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; FENTANYL; HYDROMORPHONE; IBUPROFEN; KETOROLAC; MORPHINE; NALOXONE; OPIATE; PARACETAMOL; PETHIDINE;

ADULT; AGED; AIRWAY OBSTRUCTION; ALGORITHM; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTINUOUS INFUSION; DEBUGGING METHOD; DISEASE SEVERITY; DRUG FATALITY; DRUG SAFETY; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; INFUSION PUMP; INJURY; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT ORIENTED PRESCRIPTION FOR ANALGESIA; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RESPIRATORY ARREST; UNITED STATES;

ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CARBAMATES; CLINICAL TRIALS AS TOPIC; DRUG INTERACTIONS; FEMALE; GEMFIBROZIL; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ERRORS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PAIN; PATIENT-CENTERED CARE; PIPERIDINES; SOFTWARE;

EID: 50049099153     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.24     Document Type: Article

References (57)

1. Aspden, P., Wolcott. J., Bootman, J.L. & Cronenwett, L.R. (eds.). Preventing Medication Errors: Crossing the Quality Chasm Committee on Identifying and Preventing Medication Errors (National Academies Press, Washington, DC, 2007).
2. Eccles, M., Grimshaw, J., Walker, A., Johnston, M. & Pitts, N. Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings. J. Clin. Epidemiol. 58, 107-112 (2005).
3. Bates, D.W. et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274, 29-34 (1995).
4. Shapiro, S., Slone, D., Lewis, G.P. & Jick, H. Fatal drug reactions among medical inpatients. JAMA 216, 467-472 (1971).
5. Porter, J. & Jick, H. Drug-related deaths among medical inpatients. JAMA 237, 879-881 (1977).
6. Franke, R.H. & Kaul, J.D. The Hawthorne experiments: first statistical interpretation. Am. Sociol. Rev. 43, 623-643 (1978).
7. Strom, B.L. et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA 275, 376-382 (1996).
8. Feldman, H.I. et al. Parenteral ketorolac: the risk for acute renal failure. Ann. Intern. Med. 126, 193-199 (1997).
9. Elsberry, V.A., Paxinos, J. & Harris, L.M. Preprinted physician's order form for parenteral nutrient orders. Am. J. Hosp. Pharm. 35, 779, 782 (1978).
10. Honda, D.H., Jansen, J.R., Minor, D.R. & Good, J.W. Preprinted physician's order form for intravenous cisplatin therapy. Am. J. Hosp. Pharm. 36, 742-743 (1979).
11. Kowalsky, S.F., Echols, R.M. & Peck, F. Jr. Preprinted order sheet to enhance antibiotic prescribing and surveillance. Am. J. Hosp. Pharm. 39, 1528-1529 (1982).
12. Dranitsaris, G., Leung, P. & Warr, D. Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study. Support. Care Cancer 9, 611-618 (2001).
13. Fonarow, G.C. et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch. Intern. Med. 167, 1493-1502 (2007).
14. Girotti, M.J., Fodoruk, S., Irvine-Meek, J. & Rotstein, O.D. Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work? Can. J. Surg. 33, 385-388 (1990).
15. Aswapokee, N., Vaithayapichet, S. & Komoltri, C. The failure of a preprinted order form to alter physicians' antimicrobial prescribing pattern. J. Med. Assoc. Thai. 75, 223-230 (1992).
16. Cohen, M.R. & Davis, N.M. Developing safe and effective preprinted physician's order forms. Hosp. Pharm. 27, 508, 513, 528 (1992).
17. Minsky, M. Why programming is a good medium for expressing poorly understood and sloppily formulated ideas. In Design and Planning II (eds. Krampen, M. & Seitz, P.) 120-125 (Visual Committee Books, Hasting House, NY, 1967).
18. Dijkstra, E.W. Go-to statement considered harmful. Commun. ACM 11, 147-148 (1968).
19. Gruenberger, F. Program testing and validating. Datamation 14, 39-47 (1968).
20. Weingarten, S. Practice guidelines and prediction rules should be subject to careful clinical testing. JAMA 277, 1977-1978 (1997).
21. Shekelle, P.G. et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA 286, 1461-1467 (2001).
22. Cabana, M.D. et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282, 1458-1465 (1999).
23. Neale, G., Vincent, C. & Darzi, S.A. The problem of engaging hospital doctors in promoting safety and quality in clinical care. J.R. Soc. Health 127, 87-94 (2007).
24. Nishisaki, A., Keren, R. & Nadkarni, V. Does simulation improve patient safety? Self-efficacy, competence, operational performance, and patient safety. Anesthesiol. Clin. 25, 225-236 (2007).
25. Tamuz, M. & Harrison, M.I. Improving patient safety in hospitals: contributions of high-reliability theory and normal accident theory. Health Serv. Res. 41, 1654-1676 (2006).
26. Nebeker, J.R., Hoffman, J.M., Weir, C.R., Bennett, C.L. & Hurdle, J.F. High rates of adverse drug events in a highly computerized hospital. Arch. Intern. Med. 165, 1111-1116 (2005).
27. Graumlich, J.F., Belknap, S.M., Bullard, S.A., Storm, G.A., Brunsman, K.S. & Howerton, J.A. Pharmaceutical care of postoperative nausea and vomiting: balanced scorecard for outcomes. Pharmacotherapy 20, 1365-1374 (2000).
28. Kaplan, R.S. & Norton, D.P. The balanced scorecard - measures that drive performance Harv. Bus. Rev. 70, 71-79 (1992).
29. Desbiens, N.A. et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. For the SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Crit. Care Med. 24, 1953-1961 (1996).
30. Price, D.D., Bush, F.M., Long, S. & Harkins, S.W. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 56, 217-226 (1994).
31. Gillies, G., Kenny, G., Bullingham, R. & McArdle, C. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 42, 727-731 (1987).
32. Parker, R.K., Holtmann, B., Smith, I. & White, P.F. Use of ketorolac after lower abdominal surgery. Effect on analgesic requirement and surgical outcome. Anesthesiology 80, 6-12 (1994).
33. Dahl, V., Raeder, J.C., Drosdal, S., Wathne, O. & Brynildsrud, J. Prophylactic oral ibuprofen or ibuprofen-codeine versus placebo for postoperative pain after primary hip arthroplasty. Acta Anaesthesiol. Scand. 39, 323-326 (1995).
34. Delbos, A. & Boccard, E. The morphine-sparing effect of propacetamol in orthopedic postoperative pain. J. Pain Symptom. Manage. 10, 279-286 (1995).
35. Camu, F., Van Aken, H. & Bovill, J.G. Postoperative analgesic effects of three demand-dose sizes of fentanyl administered by patient-controlled analgesia. Anesth. Analg. 87, 890-895 (1998).
36. Berde, C.B., Lehn, B., Yee, J.D., Sethna, N.F. & Russo, D. Patient-controlled analgesia in children and adolescents: a randomized, prospective comparison with intramuscular morphine for postoperative analgesia. J. Pediatr. 118, 460-466 (1991).
37. Hunt, R., Fazekas, B., Thorne, D. & Brooksbank, M. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J. Pain Symptom Manage. 18, 111-119 (1999).
38. Watanabe, S., Pereira, J., Hanson, J. & Bruera, E. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. J. Pain Symptom Manage. 16, 323-326 (1998).
39. Mercadante, S., Caligara, M., Sapio, M., Serretta, R. & Lodi, F. Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure. J. Pain Symptom Manage. 13, 241-244 (1997).
40. Paix, A. et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 63, 263-269 (1995).
41. Bjorkman, S., Wada, D.R. & Stanski, D.R. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 88, 657-667 (1998).
42. Belknap, S.M. The Chicago Kinetic Simulator: a Mathematical program for the simulation and optimization of mathematical models. Math. J. 1, 68-86 (1991).
43. Miller, R.S., Peterson, G.M., Abbott, F., Maddocks, I., Parker, D. & McLean, S. Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients. Br. J. Clin. Pharmacol. 40, 553-556 (1995).
44. Lehmann, K.A. Patient controlled analgesia for postoperative pain. In Advances in Pain Research and Therapy (eds. Benedetti, C., Chapman, C.R. & Girou, G.) 297-324 (Raven Press, New York, 1984).
45. Diaz, M. & Neuhauser, D. Pasteur and parachutes: when statistical process control is better than a randomized controlled trial. Qual. Saf. Health Care 14, 140-143 (2005).
46. Berwick, DM. Continuous improvement as an ideal in health care. N. Engl. J. Med. 320, 53-56 (1989).
47. Laffel, G. & Blumenthal, D. The case for using industrial quality management science in health care organizations. JAMA 262, 2869-2873 (1989).
48. Blumenthal, D. Quality of health care. Part 4: the origins of the quality-of-care debate. N. Engl. J. Med. 335, 1146-1149 (1996).
49. Norberg, A., Christopher, N.C., Ramundo, M.L., Bower, J.R. & Berman, S.A. Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter. JAMA 289, 726-729 (2003).
50. Naranjo, C.A. et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30, 239-245 (1981).
51. Nebeker, J.R., Barach, P. & Samore, M.H. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann. Intern. Med. 140, 795-801 (2004).
52. Hafner, J.W. Jr, Belknap, S.M., Squillante, M.D. & Bucheit, K.A. Adverse drug events in emergency department patients. Ann. Emerg. Med. 39, 258-267 (2002).
53. Ryan, B. & Gross, N.C. The diffusion of hybrid corn in two Iowa communities. Rural Sociol. 8, 15-24 (1943).
54. Coleman, J., Menzel, H. & Katz, E. Social processes in physicians' adoption of a new drug. J. Chronic Dis. 9, 1-19 (1959).
55. Yarnold, P.R., Soltysik, R.C. & Bennett, C.L. Predicting in-hospital mortality of patients with AIDS-related Pneumocystis carinii pneumonia: an example of hierarchically optimal classification tree analysis. Stat. Med. 16, 1451-1463 (1997).
56. Yarnold, P.R. & Soltysik, R.C. Optimal Data Analysis: A Guidebook With Software for Windows. (APA Books, Washington, DC, 2004).
57. 2 from contingency tables, and the calculation of P. J. R. Stat. Soc. 85, 87-94 (1922).